Michael Haude

Overview

Best Publications

• Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention : A Consensus Document From the Academic Research Consortium for High Bleeding Risk

  Philip Urban;Roxana Mehran;Roisin Colleran;Dominick J. Angiolillo

  1329
  Citations

• Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial

  Raimund Erbel;Carlo Di Mario;Jozef Bartunek;Johann Bonnier

  1065
  Citations

• Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

  Patrick W. Serruys;Ben Van Hout;Hans Bonnier;Victor Legrand

  894
  Citations

• Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

  Pascal Vranckx;Marco Valgimigli;Peter Jüni;Christian Hamm

  761
  Citations

• A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

  Patrick W Serruys;Bernard Chevalier;Dariusz Dudek;Angel Cequier

  706
  Citations

• Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

  Patrick W Serruys;Bernard Chevalier;Yohei Sotomi;Angel Cequier

  591
  Citations

• Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

  Davide Capodanno;Anna S. Petronio;Bernard D. Prendergast;Helene Eltchaninoff

  524
  Citations

• Coronary microembolization: from bedside to bench and back to bedside.

  Gerd Heusch;Petra Kleinbongard;Dirk Böse;Bodo Levkau

  500
  Citations

• Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

  Michael Haude;Raimund Erbel;Paul Erne;Stefan Verheye

  495
  Citations

• Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology.

  Martial Hamon;Christian Pristipino;Carlo Di Mario;James Nolan

  477
  Citations

• Prognostic Value of Intracoronary Flow Velocity and Diameter Stenosis in Assessing the Short- and Long-term Outcomes of Coronary Balloon Angioplasty: The DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe)

  P.W. Serruys;C. di Mario;J.J. Piek;E. Schroeder

  427
  Citations

• Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.

  R Erbel;M Haude;H W Höpp;D Franzen

  400
  Citations

• Percutaneous Mitral Annuloplasty for Functional Mitral Regurgitation Results of the CARILLON Mitral Annuloplasty Device European Union Study

  Joachim Schofer;Tomasz Siminiak;Michael Haude;Jean P. Herrman

  400
  Citations

• Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

  Michael Haude;Hüseyin Ince;Alexandre Abizaid;Ralph Toelg

  400
  Citations

• Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.

  Bernard Iung;Victoria Delgado;Raphael Rosenhek;Susanna Price

  393
  Citations

• Percutaneous Left Ventricular Support With the Impella 2.5 Assist Device in Acute Cardiogenic Shock - Results of the Impella EUROSHOCK-Registry

  Alexander Lauten;Annemarie E. Engström;Christian Jung;Klaus Empen

  391
  Citations

• Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging.

  J Ge;R Erbel;H J Rupprecht;L Koch

  371
  Citations

• Comparison of Electron Beam Computed Tomography With Intracoronary Ultrasound and Coronary Angiography for Detection of Coronary Atherosclerosis

  Dietrich Baumgart;Axel Schmermund;Guenter Goerge;Michael Haude

  365
  Citations

• Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo

  Clemens von Birgelen;Wolfgang Klinkhart;Gary S Mintz;Alexandra Papatheodorou

  328
  Citations

• Letter by Xia regarding article, "High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor".

  Gregor Theilmeier;Christoph Schmidt;Jörg Herrmann;Petra Keul

  4
  Citations